Polyplastics announces commercial availability of DURACON POM

Polyplastics has announced the commercial availability of its DURACON POM (Polyoxymethylene/Acetal) PM Series for medical applications. The company will supply materials to all global regions including Asia such as China and India, and Europe and the U.S.

Polyplastics has served the medical and healthcare field for decades with its high-purity TOPAS COC (cyclic olefin copolymer). As the world’s leading POM manufacturer, Polyplastics now adds the PM Series to its medical grade portfolio and plans to expand material supply to the medical and healthcare market. 

Polyplastics’ two acetal grades include a standard viscosity grade, PM09S01N, which delivers the mechanical properties and moldability expected from POM. Also, a high-flow grade, PM27S01N, will enable wall-thinning, miniaturisation, and light weighting of medical devices that are becoming more complex and highly functional.

These grades meet medical device manufacturers’ requirements and are targeted for a wide range of applications such as drug contact and delivery. Both grades offer global market regulatory compliance including ISO 10993 and USP Class VI biocompatibility/cytotoxicity, FDA Drug Master File (DMF) and Device Master File (MAF), and EU 10/2011 and FDA food contact 21 CFR 177.2470. The materials can be sterilised under hot steam and ethylene oxide (EtO) sterilisation conditions.

The PM series adheres to quality management systems including conformity to the VDI 2017 medical-grade plastics standard. They also provide full traceability of processes and products, and production management based on GMP principles.